PERFECT BETA-TYPE NMNPURE
TANAKA, Megumi
Application Filed: 2020-07-17
Trademark Application Details
STATEMENT OF USE - TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90980773 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Adam Weiss |
| Attorney Docket Number | 9UST376/6 |
| Law Office Assigned | L10 |
| Employee Name | STOIDES, KATHERINE |
Timeline
| 2020-07-17 | Application Filed |
| 2021-01-12 | Published for Opposition |
| 2023-09-10 | Date of First Use |
| 2024-01-29 | Location: TMEG LAW OFFICE 101 |
| 2024-01-29 | Status: Live/Pending |
| 2024-01-29 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  TANAKA, Megumi |
| Address | GrandMaison Higashikaiganminami 2-11-24- Higashikaiganminami Chigasaki-shi, Kanagawa JP 2530054 |
| Legal Entity Type | Joint Ownership |
| Legal Entity State | JP |
| Owner: | TANAKA, Tsunemaru |
| Address | GrandMaison Higashikaiganminami 2-11-24- Higashikaiganminami Chigasaki-shi, Kanagawa JP 2530054 |
| Legal Entity Type | Joint Ownership |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Dietary supplements containing nicotinamide mononucleotides |
| GS0051 | Dietary supplements containing nicotinamide mononucleotides |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2020-07-21 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2020-08-13 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-10-31 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2020-11-10 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2020-11-10 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-11-10 | 6 GNEN O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2020-11-10 | 7 ALIE A:Allowance for Publication |
| EXAMINER'S AMENDMENT ENTERED | 2020-11-10 | 8 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-12-08 | 9 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-12-23 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-01-12 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-01-12 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-03-09 | 13 NOAM E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2021-09-05 | 14 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2021-09-05 | 15 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2021-09-05 | 16 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-09-07 | 17 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2022-03-06 | 18 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2022-03-06 | 19 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2022-03-06 | 20 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-03-08 | 21 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2022-07-29 | 22 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2022-07-29 | 23 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2022-07-29 | 24 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-08-02 | 25 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-03-08 | 26 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2023-03-08 | 27 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2023-03-08 | 28 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-03-10 | 29 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-09-10 | 30 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-09-18 | 31 AITU A:Allowance for Publication |
| TEAS REQUEST TO DIVIDE RECEIVED | 2023-09-07 | 32 ERTD I:Incoming Correspondence |
| REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN | 2023-11-28 | 33 UNTD O:Outgoing Correspondence |
| SOU EXTENSION 5 FILED | 2023-09-10 | 34 EXT5 S: |
| TEAS REQUEST TO DIVIDE RECEIVED | 2023-09-07 | 35 ERTD I:Incoming Correspondence |
| REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN | 2023-11-28 | 36 UNTD O:Outgoing Correspondence |
| SOU EXTENSION 5 FILED | 2023-09-10 | 37 EXT5 S: |
| SOU EXTENSION 5 GRANTED | 2023-11-28 | 38 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-11-29 | 39 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2023-11-30 | 40 EISU I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2023-11-30 | 41 ERTD I:Incoming Correspondence |
| DIVISIONAL REQUEST RECEIVED | 2023-11-30 | 42 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2024-01-29 | 43 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2023-11-30 | 44 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2024-01-29 | 45 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2024-03-06 | 46 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2024-03-07 | 47 SUNA E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 